We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+23.47%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$558M
AUM Growth
+$37.6M
(+7.2%)
Cap. Flow
-$24.1M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
112
New
24
Increased
27
Reduced
29
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$6.49M |
| 2 |
Molina Healthcare
MOH
|
+$6.13M |
| 3 |
Centene
CNC
|
+$5.55M |
| 4 |
DexCom
DXCM
|
+$5.21M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WW
WW International
WW
|
+$12.1M |
| 2 |
Etsy
ETSY
|
+$6.63M |
| 3 |
Autodesk
ADSK
|
+$5.08M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.16M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.91% |
| 2 | Technology | 14.91% |
| 3 | Communication Services | 9.68% |
| 4 | Consumer Discretionary | 8.3% |
| 5 | Materials | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ashland
ASH
$3.29B
| $6.98M | 1.25% |
83,200
-1,800
| -2% | -$150K |
|
|
27
Elevance Health
ELV
$83B
| $6.85M | 1.23% |
+25,000
| New | +$6.49M |
|
28
Atlassian
TEAM
$26.3B
| – | – |
0
| – | – |
|
29
Shake Shack
SHAK
$2.61B
| $6.55M | 1.18% |
104,000
+34,000
| +49% | +$2.06M |
|
|
PVTL
30
DELISTED
Pivotal Software, Inc.
PVTL
| $6.46M | 1.16% |
330,000
+5,000
| +2% | +$122K |
|
|
SIEN
31
DELISTED
Sientra, Inc.
SIEN
| $6.13M | 1.1% |
25,660
+9,660
| +60% | +$2.12M |
|
|
GRA
32
DELISTED
W.R. Grace & Co.
GRA
| $5.93M | 1.06% |
83,000
-6,000
| -7% | -$433K |
|
|
WWE
33
DELISTED
World Wrestling Entertainment
WWE
| $5.8M | 1.04% |
60,000
-24,000
| -29% | -$1.98M |
|
|
34
Centene
CNC
$31.5B
| $5.79M | 1.04% |
+80,000
| New | +$5.55M |
|
|
MDCO
35
CALL
DELISTED
Medicines Co
MDCO
| $5.46M | 0.98% |
182,500
+7,500
| +4% | +$283K |
|
|
ECYT
36
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $5.42M | 0.97% |
305,000
+10,000
| +3% | +$172K |
|
37
Inspire Medical Systems
INSP
$1.5B
| $5.32M | 0.95% |
126,400
+38,900
| +44% | +$1.83M |
|
38
Insulet
PODD
$11.8B
| $5.19M | 0.93% |
49,000
-14,000
| -22% | -$1.31M |
|
|
39
Bio-Rad Laboratories Class A
BIO
$8.96B
| $5.16M | 0.93% |
+16,500
| New | +$5.12M |
|
40
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $5.03M | 0.9% |
51,900
-5,000
| -9% | -$499K |
|
|
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.01M | 0.9% |
+29,000
| New | +$4.18M |
|
|
TWOU
42
DELISTED
2U Inc
TWOU
| $5M | 0.9% |
2,217
-50
| -2% | -$124K |
|
43
Tandem Diabetes Care
TNDM
$1.38B
| $4.93M | 0.88% |
+115,000
| New | +$4.02M |
|
44
argenx
ARGX
$52B
| $4.83M | 0.87% |
63,630
+3,620
| +6% | +$321K |
|
45
Five Below
FIVE
$12B
| $4.81M | 0.86% |
37,000
+4,000
| +12% | +$445K |
|
|
EB
46
DELISTED
Eventbrite
EB
| $4.75M | 0.85% |
+125,000
| New | +$4.52M |
|
47
EPAM Systems
EPAM
$5.6B
| $4.71M | 0.84% |
34,200
-800
| -2% | -$108K |
|
48
CALL
Bristol-Myers Squibb
BMY
$134B
| $4.66M | 0.84% |
75,000
| – | – |
|
49
Liberty Media Series C
FWONK
$24.5B
| $4.57M | 0.82% |
127,218
-17,582
| -12% | -$621K |
|
|
GRUB
50
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $4.44M | 0.8% |
+16,000
| New | +$4.13M |
|
Similar funds
AGA
RIM
ACM
CAM
LSA
GWA
HP
Atika Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Atika Capital Management held 112 positions worth $558M, up 7.2% from $520M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Atika Capital Management withdrew a net $24.1M in Q3 2018, closing 27 positions and reducing 29 holdings. Its most notable exit was WW International, an estimated $12.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in Elevance Health worth $6.85M.
- Atika Capital Management's largest Q3 2018 buy was Elevance Health: 25,000 shares worth $6.85M.
- Atika Capital Management added most to DexCom in Q3 2018, an estimated $5.21M increase.
- Atika Capital Management's biggest Q3 2018 reduction was Etsy, cutting an estimated $6.63M.
- Atika Capital Management fully exited WW International in Q3 2018, selling an estimated $12.1M.
- Atika Capital Management's ten largest holdings make up 34% of its $558M portfolio in Q3 2018.
- Atika Capital Management opened 24 new positions and closed 27 in Q3 2018.
- Atika Capital Management's portfolio value rose 7.2% quarter-over-quarter to $558M.
Based on Atika Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.